SARAS CAPITAL β Full Portfolio
11 tracked investments Β· listed companies and verified rows first
Kyron.bio is a biotechnology company focused on developing therapeutic drugs, with an in-house R&D and laboratory operation.
BiotechDeep TechHealthtechParis, FR
Emilia McLaughlin(Cofounder)in
Co-investorsEntrepreneur FirstHCVCVerve VenturesGSV Ventures
.jpeg){kind=logo}
NanoSyrinx develops a technology platform for biopharmaceutical applications, with expertise in drug discovery, cell therapy, and biologic development.
AI & Machine LearningBiotechDeep TechMedical DevicesCoventry, GB
Dr. Joe Healey(Founder)Dr. Nick Waterfield(Founder)Dr. Alexia Hapeshi(Founder)Joe(Founder and former CEO)Nick(Scientific Advisor and Co-founder)Thomas J. Farrell(CEO)
Co-investorsIQ CapitalOctopus VenturesFuture Planet CapitalM Ventures
.jpeg){kind=logo}
Graphica applies foundational AI models to precision plant breeding, genetics and molecular biology, building plants and biological products.
AgTechAI & Machine LearningBiotechLondon, GB
Cecy Price(CEO)inDominic Hall(CTO)in
Co-investorsEntrepreneur FirstFaberFaber Capital SCR SANucleus CapitalSie VenturesSuperSeed+4 more
Cellbyte automates regulatory workflows and data analysis for pharmaceutical drug launches, helping manufacturers prepare treatments for global markets faster.
AI & Machine LearningEnterprise SoftwareHealthtechMedical DevicesSaaSMunich, DE
Felix Steinbrenner(Co-Founder & CEO)inDanielSamuel
Co-investorsFrontline VenturesPace VenturesY CombinatorSpringboard Health Angels
Converge is an AI-native growth platform for direct-to-consumer brands that automates media buying, attribution analysis, and reporting through agentic AI.
AdTechAI & Machine LearningDirect to ConsumerE-commerceEnterprise SoftwareSaaSNew York City, US
Jan-Henrik Lambrechts(Founder)inJerome Billiet(Founder)inThomas Holvoet(Founder)in
Co-investorsEntourage VenturesY CombinatorBessemer Venture PartnersTLV PartnersVintage Investment Partners
Converge is an insurtech company that underwrites cyber risk insurance, distributing coverage to broker-partners across the U.S. through a capacity partnership with QBE.
AI & Machine LearningCybersecurityFintechInsurTech
Steven Petrevski(Founder)inTom Kang(Chief Executive Officer)Howie Altman(Chief Technology Officer)in
Co-investorsForgePoint CapitalBessemer Venture PartnersTLV PartnersVintage Investment Partners
Converge Bio develops generative AI models trained on DNA, RNA, and protein sequences to support drug discovery and development for biotech and pharmaceutical companies.
AI & Machine LearningBiotechDeep TechClaymont, US
Dov Gertz(CEO & Co-Founder)inOded Kalev(CTO & Co-Founder)inIddo Weiner(CSO & Co-Founder)in
BoardShahar Tzafrir(Director)inAndrew Hedin(Director)in
Co-investorsBessemer Venture PartnersTLV PartnersVintage Investment Partners
Eden Bio develops machine-learning technology for genetic engineering and protein yield optimization across food, pharmaceutical, and biofuel industries.
AI & Machine LearningBiotech
Co-investorsSynBioVenUnruly CapitalSemantic Ventures
Parse provides cloud-based backend infrastructure and tools for developers to build applications across mobile, desktop, and embedded platforms, including data storage, push notifications, and usage analytics.
Developer ToolsEnterprise SoftwareSan Francisco, US
Kevin Lacker(Founder/CTO)in
Co-investorsY Combinator
Parse provides an API platform that converts web actions and data retrieval from any website into single API calls without running a browser.
Data & InfrastructureDeveloper ToolsEnterprise SoftwareSaaSSan Francisco, US
Alex Forman(Founder)in
Co-investorsY Combinator
Parse.ly is a content analytics and audience intelligence platform offering a real-time dashboard, a content recommendation API, a data pipeline to warehouses, and AI-driven insights.
Data & InfrastructureMarketing TechMedia & Entertainment
Co-investorsHaatchHorizon Technology FinanceJanus Henderson InvestorsSahsen VenturesSoleus Capital
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.